Biora Therapeutics granted extension to regain compliance with Nasdaq Source: Seekingalpha
Browsing: granted
ENDRA Life Sciences granted extension to regain compliance with Nasdaq continued listing requirements Source: Seekingalpha
Soleno lead asset granted FDA priority review Source: Seekingalpha
Soleno lead asset granted FDA priority review Source: Seekingalpha
Soleno lead asset granted FDA priority review Source: Seekingalpha
